CG Oncology, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue 0.20M1.14M
Gross Profit 0.20M1.14M
Operating items
Research & Development 45.75M82.10M
Selling, General & Administrative 9.90M33.70M
Operating Expenses 55.65M115.81M
Operating Income -55.45M-114.67M
EBIT -55.45M-114.67M
Non-operating items
Interest & Investment Income 6.90M26.62M
Other Non Operating Income -0.06M0.00M
Non Operating Income 6.84M26.63M
Net income details
EBT -48.55M-88.04M
Profit After Tax -48.61M-88.04M
Income from Continuing Operations -48.55M-88.04M
Consolidated Net Income -48.55M-88.04M
Income towards Parent Company -48.55M-88.04M
Preferred Dividend Payments 18.78M
Net Income towards Common Stockholders -67.80M-88.04M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 43.48M67.63M
Shares Outstanding (Diluted Average) 4.33M62.50M
EBITDA -55.45M-114.67M
Shares Outstanding 5.22M76.15M